MILESTONE (MMD): Milestone Medical Annopuces Planned Road Show in Warsaw - April 2014 - raport 8

Contact:

Crescendo Communications Europe Sp. z o.o.

Poland Tel: (+48 71) 79 11 555

U.S. Tel: +1-212-671-1020

Email: mmd@crescendo-ir.com

Milestone Medical Inc. Announces Planned Roadshow in Warsaw to Meet with Investors

LIVINGSTON, NJ, March XX, 2014 -- Milestone Medical Inc. (WAR: MMD), today announced a planned Warsaw road show in which management will meet with both new and existing institutional and high net worth investors from April 7th - 11th, 2014.

Milestone Medical will conduct one-on-one meetings, including a corporate overview and Q&A session. Crescendo Communications, a leading investor relations firm with offices in Warsaw, New York, Moscow, Beijing, Tbilisi and Hong Kong, will organize the meetings.

Leonard Osser, CEO of Milestone Medical, stated, “Meeting in person with our Poland investors and furthering the Milestone Medical story is an important element to maximizing shareholder value. 2014 will be a very active year on the business development front and we plan to keep the investment community abreast of all current and future developments. I look forward to meeting with investors in Warsaw and will continue to do so on a regular basis."

To set up a meeting with Milestone Medical while they are in Warsaw (Monday, April 7th to Friday, April 11th), please email mmd@crescendo-ir.com with your name, company and availability.

About Milestone Medical Inc.

Milestone Medical, Inc. has developed epidural and intra-articular drug delivery systems based on a patented, painless, computer-controlled injection and drug delivery technology originally developed by Milestone Scientific, Inc. Development of both the epidural and intra-articular instruments is now complete and the Company is currently pursuing marketing permission for both instruments in the U.S. and European Union. For more information please visit www.medicalmilestone.com.

About Crescendo Communications Europe

Crescendo Communications Europe, headquartered in Warsaw with offices in New York, Moscow, Hong Kong and Tbilisi, is an emerging leader within the investor relations industry. The firm was founded on a strategic and professional approach to investor relations that builds awareness of public companies through tailored outreach programs that target institutional investors, analysts, and the financial media. The firm's approach is centered around properly educating investors and cultivating trust within the global capital markets. Additional information is available at www.crescendo-ir.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Osoby reprezentujące spółkę:
Joseph D'Agostino - CFO